[1] Hui M L, Fang F S, Yue X B, et al. Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection[J]. Hepatol Int,2023,17(1):42-51. [2] 陆伟, 张占卿, 阎俪, 等. 血清定量HBsAg和HBV DNA预测HBeAg阳性慢性HBV感染显著肝炎活动的性能比较[J]. 肝脏,2023,28(1):86-94. [3] Eveline H, Bernard S, Blanco N B, et al. Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV Coinfection[J].Clin Infect Dis,2023,76(4):730-733. [4] 唐建华, 陈富强, 孙晓军, 等. 乙肝患者血清lncRNA NEAT1表达与HBV DNA载量,肝功及T淋巴细胞亚群的相关性[J]. 中国病原生物学杂志,2021,16(5):582-585,589. [5] 桑珍珍, 高杰, 贾春梅, 等. 血清microRNA-122a、microRNA-124a及microRNA-125b对脓毒症休克并发肝损伤早期诊断及预后评估的临床价值[J]. 中国现代医学杂志,2020,30(2):27-33. [6] Eyileten C, Fitas A, Jarosz P J, et al. MicroRNA-223 might be a predictive biomarker for major adverse cardiovascular events prognosis in patients undergoing transcatheter aortic valve implantation procedur[J]e. Eur Heart J,2021,42(1):1-3. [7] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 中华传染病杂志,2019,37(12):711-736. [8] 祝方, 尹向东, 刘刚, 等. 深圳市罗湖乙肝综合防治示范区劳务工人乙肝病毒感染状况调查[J]. 中国公共卫生,2022,38(3):271-275. [9] 付甜甜, 姚钊, 丁红, 等. 计算机辅助诊断慢性乙肝患者肝纤维化进程的价值分析[J]. 中华医学杂志,2019,99(7):491-495. [10] Richard K S, Wendy C K, Mandana K, et al. Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults[J]. Dig Dis Sci,2022,67(2):676-688. [11] 潘正兰, 管世鹤, 陈礼文, 等. IL-6过表达慢病毒稳转细胞系构建及其对HBsAg、HBeAg、HBV DNA表达影响[J]. 安徽医科大学学报,2019,54(4):594-599,604. [12] 王庆辉, 蒋瑞馨, 夏卫, 等. 隐匿性乙型肝炎病毒感染相关miRNAs筛选及其生物信息学分析[J]. 中国输血杂志,2020,33(3):217-222. [13] 杜波, 高小丽, 白雪梅. 慢性乙型肝炎患者HBV DNA载量与血清microRNA-122,ALT的相关性研究[J]. 中国现代医学杂志,2020,30(24):86-90. [14] 徐静, 张凤岐, 王聪, 等. 血清miR-223, HMGB1与乙肝患者HBV DNA载量和肝功能的关系研究[J]. 国际病毒学杂志,2021,28(4):332-335. [15] Sarah A E R, Sloan D J, Wilna O, et al. MicroRNA-122 and cytokeratin-18 have potential as a biomarkers of drug-induced liver injury in European and African patients on treatment for mycobacterial infection[J]. Br J Clin Pharmacol,2021,87(8):3206-3217. [16] 袁冲, 赵征, 廖子君, 等. 血清miR-122和miR-570联合检测对原发性肝癌的临床诊断价值[J]. 现代肿瘤医学,2021,29(2):267-270. [17] 罗艳香, 程含, 吴波, 等. 慢性HBV感染血清miR-122和miR-155与miR-375表达及意义[J]. 中华医院感染学杂志,2021,31(21):3230-3234. [18] 龚晓媛, 万舒淇, 傅承宏. 乙型病毒肝炎及晚期肝纤维化患者血清中miR-223的表达及临床意义[J]. 中国病原生物学杂志,2021,16(10):1202-1206. [19] 李丽敏, 秦雪. miR-223在原发性肝癌患者血清中的表达及临床意义. 广西医科大学学报[J],2019,36(5):808-811. [20] Shareef S, Ebrahimi S O. Contribution of hsa-miR-146a and hsa-miR-223 gene variations in patients with multiple sclerosis reveals association of rs2910164 and rs1044165 with risk of multiple sclerosis susceptibility[J]. J Investig Med,2021,69(5):1015-1021. [21] Heba E A, Nadia E G, Enas M R, et al. Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients[J]. Asian Pac J Cancer Prev,2022,23(12):4125-4135. |